Nicotinamide adenine dinucleotide, a coenzyme critical for cellular energy metabolism that declines with age. NAD+ precursors like NMN and NR are studied as longevity interventions.

Mechanistic target of rapamycin, a key nutrient-sensing pathway that regulates cell growth and aging. Inhibiting mTOR (e.g., with rapamycin) has shown lifespan extension in multiple organisms.

A class of drugs that selectively eliminate senescent (aged, dysfunctional) cells to reduce inflammation and improve tissue function.

What is Epigenetic clock?

A biomarker based on DNA methylation patterns that estimates biological age, often more predictive of health outcomes than chronological age.

The period of life spent in good health, free from chronic diseases and disability associated with aging.

An immunosuppressant drug that inhibits the mTOR pathway. Research shows rapamycin may extend lifespan and improve age-related health outcomes in multiple species.

What is Biological age?

A measure of how well or poorly your body is functioning relative to your chronological age, assessed through biomarkers such as DNA methylation, telomere length, and blood panels.

What is Caloric restriction?

A dietary regimen that reduces calorie intake without malnutrition. Caloric restriction is one of the most studied interventions shown to extend lifespan across species.

Protective caps at the ends of chromosomes that shorten with each cell division. Telomere length is associated with aging and age-related diseases.

A state in which cells permanently stop dividing but resist death, accumulating with age and secreting inflammatory factors that damage surrounding tissue.

A second-generation epigenetic clock that predicts time to death and is considered one of the most accurate measures of biological aging.

What is Inflammaging?

Chronic, low-grade inflammation that increases with age and contributes to the development of age-related diseases including cardiovascular disease, diabetes, and neurodegeneration.

The large-scale study of proteins in biological systems. In longevity research, proteomics identifies blood protein signatures that predict biological age and disease risk.

What is Yamanaka factors?

A set of four transcription factors (Oct4, Sox2, Klf4, c-Myc) that can reprogram adult cells to a pluripotent state. Partial reprogramming with Yamanaka factors is being explored to reverse cellular aging.

Nicotinamide mononucleotide, a precursor to NAD+ that is widely studied as a supplement to boost cellular energy and combat age-related decline.

A gene-editing technology that allows precise modifications to DNA. In longevity research, CRISPR is used to study and potentially modify genes associated with aging.

A cellular housekeeping process where cells break down and recycle damaged components. Declines with age and is stimulated by fasting.

What is Intermittent fasting?

An eating pattern that cycles between periods of fasting and eating. Various protocols (16:8, 5:2) are studied for metabolic, cardiovascular, and longevity benefits.

What is Zone 2 cardio?

Low-intensity aerobic exercise performed at roughly 60–70% of maximum heart rate, primarily using the aerobic energy system. Associated with mitochondrial health and longevity.

Geographic regions identified by researchers where people consistently live longer and healthier lives than average, including Sardinia, Okinawa, and Loma Linda.

Why Aging Well is Key to Economic Health

Researchers argue that transforming our approach to aging is not just a health issue but an economic necessity. The current healthcare system spends trillions treating diseases linked to aging, such as diabetes and heart disease, while neglecting the root causes of these conditions. This reactive model is likened to trying to bail water from a sinking ship without fixing the hole. By shifting towards preventative biomedical repair, we can reduce healthcare costs and improve quality of life, ultimately benefiting society as a whole.

For individuals looking to age well, this shift could mean better management of health and longevity. By addressing the biological processes of aging, people could experience fewer chronic diseases and maintain a higher quality of life for longer. The World Economic Forum’s 2026 Longevity Dividend Report highlights that addressing population aging could significantly drive national economic growth, suggesting that healthy aging is crucial not only for personal well-being but also for economic stability.

The evidence indicates that we are at a critical juncture. Current healthcare practices, which focus on managing symptoms rather than preventing them, lead to increasing medical costs and a decline in quality of life. The article emphasizes the need for proactive interventions that target the underlying biological damage associated with aging. While the concept of rejuvenation technologies is still emerging, the potential benefits are substantial, with the possibility of extending healthy lifespans and reducing the burden on healthcare systems.

To truly benefit from advancements in rejuvenation, equitable access to these technologies is essential. If only the wealthy can afford such treatments, we risk creating a society where longevity and health are privileges rather than rights. The democratization of rejuvenation technologies could lead to healthier, longer lives for everyone, which is not only a moral imperative but also an economic one. For more details, see the full discussion on Lifespan.io.